What is MT-2 (Melanotan II)? A Researcher's Guide to the Melanocortin Receptor Agonist

Melanotan II (MT-2) is a synthetic analogue of alpha-melanocyte-stimulating hormone (α-MSH), a naturally occurring peptide derived from pro-opiomelanocortin (POMC). It is widely studied for its interactions with the melanocortin receptor system, making it a valuable compound in pigmentation, sexual function, and appetite research.

This guide covers what MT-2 is, how it works mechanistically, and why it continues to attract significant research interest.

What is MT-2?

MT-2 is a cyclic heptapeptide designed to be a more potent and stable analogue of α-MSH. It was originally synthesised at the University of Arizona as part of research into photoprotection and pigmentation. Unlike α-MSH, MT-2 is non-selective across melanocortin receptor subtypes, which broadens its research utility.

Its primary receptor targets include:

• MC1R — involved in melanogenesis and skin pigmentation
• MC3R — involved in energy homeostasis and inflammation
• MC4R — involved in sexual function, appetite regulation, and energy balance
• MC5R — involved in exocrine gland function

Mechanism of Action

MT-2 acts as an agonist at melanocortin receptors, mimicking the effects of endogenous α-MSH with greater potency and duration. MC1R activation stimulates melanin production in melanocytes, while MC4R activation has been studied extensively in the context of erectile function and libido in animal models. The broad receptor profile of MT-2 makes it a useful tool for dissecting melanocortin system pharmacology.

Why MT-2 is of Research Interest

MT-2 has been studied across several research domains due to its multi-receptor activity. Key areas include:

• Pigmentation and melanogenesis research
• Sexual dysfunction models (particularly MC4R-mediated pathways)
• Appetite suppression and energy balance studies
• Inflammation and immune modulation via MC3R
• Neuroprotection research

MT-2 vs. α-MSH

Understanding how MT-2 compares to its endogenous counterpart is important for research design:

• α-MSH — endogenous linear tridecapeptide; short half-life, selective MC1R/MC3R activity
• MT-2 — synthetic cyclic analogue; greater potency, longer half-life, broader receptor engagement across MC1R, MC3R, MC4R, and MC5R

This enhanced stability and potency make MT-2 preferable for in vivo research models where sustained receptor engagement is required.

Sourcing MT-2 for Research

Research-grade MT-2 should be sourced from suppliers providing batch-specific Certificates of Analysis (CoA) confirming purity (>98%), identity, and potency. Lyophilised formats offer optimal stability for laboratory storage.

At Aura Peptides, our MT-2 is supplied as a research-grade lyophilised peptide with full CoA documentation, available as single vials or in 10x bulk packs for high-volume research programmes.

For research purposes only. Not intended for human or veterinary use.